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ABSTRACT
Background. Elderly colorectal cancer patients have
worse prognosis than younger patients. Age-related sur-
vival differences may be cancer or treatment related, but
also due to death from other causes. This study aims to
compare population-based survival data for young
(\65 years), aged (65–74 years), and elderly (C75 years)
colorectal cancer patients.
Methods. All patients operated for stage I–III colorectal
cancer between 1991 and 2005 in the western region of The
Netherlands were included. Crude survival, relative sur-
vival, and conditional relative survival curves, under the
condition of surviving 1 year, were made for colon and
rectal cancer patients separately. Furthermore, 30-day,
1-year, and 1-year excess mortality data were compared.
Results. A total of 9,397 stage I–III colorectal cancer
patients were included in this study. Crude survival curves
showed clear survival differences between the age groups.
These age-related differences were less prominent in rela-
tive survival and disappeared in conditional relative
survival (CRS). Only in stage III disease did elderly
patients have worse CRS than young patients. Furthermore,
signiﬁcant age-related differences in 30-day and 1-year
excess mortality were found. Thirty-day mortality vastly
underestimated 1-year mortality for all age groups.
Conclusions. Elderly colorectal cancer patients who sur-
vive the ﬁrst year have the same cancer-related survival as
younger patients. Therefore, decreased survival in the
elderly is mainly due to differences in early mortality.
Treatment of elderly colorectal cancer patients should
focus on perioperative care and the ﬁrst postoperative year.
The number of elderly people in the population and the
incidence of colorectal cancer are increasing. Therefore, it
is to be expected that the number of elderly colorectal
cancer patients will further increase. Various population-
based studies show that survival of elderly colorectal
cancer patients is worse compared with younger patients.
Differences in survival by age group in colorectal cancer
may be explained by variations in tumor factors, patient
characteristics, and therapy. Elderly colorectal cancer
patients tend to have more advanced disease stage.
1
Besides, they have more comorbidity and are treated less
aggressively than their younger counterparts.
2 Comorbidity
inﬂuences surgical eligibility and other treatment options.
3
Furthermore, it represents a greater risk of non-cancer-
related mortality. Elderly patients less frequently receive
adjuvant chemotherapy and more often discontinue treat-
ment before completion.
4
Notwithstanding all these differences, several studies
found similar disease-speciﬁc survival for elderly and
young colorectal cancer patients.
5–7 This would indicate
that the excess mortality in elderly colorectal cancer
patients is due to competing causes of death. To gain better
insight into survival differences between age groups, the
present study aims to compare population-based survival
data of colorectal cancer patients for different age groups.
It considers not only overall and relative survival but also
conditional relative survival under the condition of sur-
viving 1 year. Furthermore, this study focuses on age-
related differences in 30-day and 1-year mortality.
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Patients were selected from the regional cancer registry
of the Comprehensive Cancer Centre West (CCCW) cov-
ering the western part of The Netherlands. The nationwide
Dutch Network and Registry of Histo- and Cytopathology
(PALGA) regularly submits reports of all diagnosed
malignancies to the cancer registries. The national hospital
discharge databank, which receives discharge diagnoses of
admitted patients from all Dutch hospitals, completes case
ascertainment. After notiﬁcation, trained registry personnel
collect data on diagnosis, staging, and treatment from
medical records, including pathology and surgery reports,
using the registration and coding manual of the Dutch
Association of Comprehensive Cancer Centers. Cancer
registry data show actual variations in patterns of staging,
treatment, and survival by age and therefore offer scope for
improvement of care and for creating guidelines, in addi-
tion to randomized clinical trials.
8
From the regional cancer registry, patients diagnosed
between 1991 and 2005 with their ﬁrst, primary, stage I, II
or III colon or rectal cancer who were surgically treated
were selected. Vital status was established either directly
from the patient’s medical record or through linkage of
cancer registry data with the municipal population regis-
tries which record information on their inhabitants’ vital
status. Stage was based on pathological information;
clinical information was used if pathology data were
missing.
Statistics
Patients were divided into younger than 65 years,
65–74 years, and 75 years and older. Differences between
characteristics were tested with chi-squared tests. Overall
survival was calculated with death due to any cause as
event. Relative survival is the preferred way to describe the
prognosis of elderly cancer patients, as it takes into account
the risk of dying from causes other than the disease of
interest.
8 Relative survival was calculated by the Hakulinen
method as the ratio of the survival observed among the
cancer patients and the survival that would have been
expected based on the corresponding (age, sex, and year)
general population. National life tables were used to esti-
mate expected survival. Conditional relative survival was
calculated for patients who survived the ﬁrst year. Relative
excess risks of death (RER) were estimated using a mul-
tivariate generalized linear model with a Poisson
distribution, based on collapsed relative survival data,
using exact survival times. Finally, 30-day and 1-year
overall mortality were calculated as well as the 1-year
excess mortality as (observed - expected deaths)/(number
of patients).
RESULTS
From 1 January 1991 through 31 December 2005 in the
CCCW region 9,611 stage I–III colorectal cancer patients
were diagnosed and 9,397 (97.8%) were operated, being
6,405 patients with colon cancer and 2,992 with rectal
cancer. These patients had median age of 72 years (range
7–100 years) for colon cancer and 69 years (range
18–98 years) for rectal cancer patients. Patient character-
istics according to age group for colon and rectum
separately are shown in Table 1. The percentage of female
patients was signiﬁcantly higher in the oldest age groups,
especially for colon cancer patients. The number of treated
colon cancer patients increased over the years. Tumor
grade was evenly divided for rectal cancer but not for colon
cancer patients, with more grade III in the elderly. In this
cohort, younger patients had higher tumor stage than the
elderly, although the percentage of patients with unknown
stage of disease was higher in the elderly (data not shown).
Use of adjuvant chemotherapy decreased with advancing
age groups. Radiotherapy for rectal cancer patients was
comparable for the young and aged groups and was lower
in the elderly group.
Figure 1 shows survival curves for overall survival (a),
relative survival (b), and conditional relative survival
(c) for colon and rectal cancer patients in the different age
groups. Differences in survival between age groups for
colorectal cancer patients disappeared when a correction
was made for death from other causes under the condition
of surviving 1 year. As shown in Table 2, the elderly
patients had a RER of 1.6 [95% conﬁdence interval (CI)
1.4–1.9; P\0.001] as compared with the young patients
for colon cancer and 1.4 (95% CI 1.2–1.7; P\0.001) for
rectal cancer. When relative survival was calculated for
patients who survived the ﬁrst year, relative excess risks
were around 1.0 (RER 1.1, P = 0.2 for colon; RER 1.1,
P = 0.3 for rectal cancer). Going into more detail by
considering different stages, a signiﬁcant difference in
conditional relative survival remained for stage III patients
for both colon and rectal cancer.
Table 3 shows overall 30-day, 1-year, and 1-year excess
mortality according to type of tumor in reference to base-
line factors. Gender was a signiﬁcant factor for ﬁrst-year
mortality in rectal cancer, with more male patients dying.
Age was the most signiﬁcant factor for all three mortality
endpoints for both colon and rectal cancer patients. Tumor
grade did not inﬂuence 30-day mortality but was a signif-
icant factor for 1-year mortality for both colon and rectal
cancer patients. Tumor stage also inﬂuenced 30-day mor-
tality for colon cancer patients, but not for rectal cancer
patients. Thirty-day and 1-year mortality rates decreased
over the years (data not shown). For colon cancer patients
this was only signiﬁcant (P\0.05) for 1-year mortality
1534 J. W. T. Dekker et al.rates for all age groups (lowest RER 0.94). For rectal
cancer patients, 30-day mortality was signiﬁcantly reduced
(P\0.01) for the elderly (RER 0.89). One-year mortality
for the young and aged patients (lowest RER 0.93) was
signiﬁcantly improved (P = 0.03), however not for the
elderly patients (P = 0.3; RER 0.98).
DISCUSSION
Crude survival is a solid outcome measure that shows
evident age-related differences. However, crude survival
will overestimate the impact of cancer on survival, because
it also includes mortality due to other causes. To adjust for
this, relative survival is used, deﬁned as the ratio of
observed to expected survival. This reduces age-related
differences in colorectal cancer survival. However, the
results of age-related relative survival are still largely
inﬂuenced by early mortality (deﬁned as mortality in the
ﬁrst postoperative year). Postoperative complications are a
more probable cause for early mortality than the colorectal
cancer itself in stage I–III patients (who, in general, had
curative surgery). Therefore, to get a clear image of the
impact of colorectal cancer on survival for different age
groups, we used conditional relative survival under the
condition of surviving 1 year. As a result, age-related dif-
ferences in survival disappeared, indicating that probably
colorectal cancer itself is not the main cause of age-related
differences in survival. This is in line with earlier studies
that found no age-related differences in cancer-speciﬁc
survival.
5–7 However, this remains intriguing, since many
papers indicate that differences in survival between the
young and the elderly can be attributed to undertreatment
in the elderly.
1,9 Our study conﬁrms these variations in
treatment and that conditional survival in stage III patients
is indeed signiﬁcantly worse in the elderly. Nonetheless,
the excess mortality in the ﬁrst postoperative year was the
main determining factor for age-related survival
differences.
Postoperative Mortality
The 30-day mortality rates for the different age groups
in the present study are in accordance with earlier ﬁndings
by other studies.
10,11 However, the most striking ﬁnding of
this analysis is the fact that 30-day mortality vastly
underestimates 1-year mortality for all age groups.
TABLE 1 Characteristics of patients operated for colon and rectal cancer diagnosed in the period 1991–2005 according to age
Colon cancer Rectal cancer
\65.0 years,
number (%)
65–74 years,
number (%)
C75 years,
number (%)
P-
Value
\65.0 years,
number (%)
65–74 years,
number (%)
C75 years,
number (%)
P-
Value
Sex
Male 889 (51.1) 964 (50.3) 1,123 (40.8) \0.001 603 (57.6) 513 (57.5) 523 (49.7) \0.001
Female 851 (48.9) 952 (49.7) 1,626 (59.2) 444 (42.4) 379 (42.5) 530 (50.3)
Year
1991–1995 539 (31.0) 624 (32.6) 831 (30.2) 0.02 307 (29.3) 295 (33.1) 342 (32.5) 0.2
1996–2000 531 (30.5) 642 (33.5) 930 (33.8) 326 (31.1) 281 (31.5) 343 (32.6)
2001–2005 670 (38.5) 650 (33.9) 988 (36.0) 414 (39.6) 316 (35.4) 368 (34.9)
Grade
Grade I 123 (7.1) 129 (6.7) 184 (6.7) 0.02 62 (5.9) 44 (4.9) 56 (5.3) 0.4
Grade II 1,150 (66.1) 1,326 (69.2) 1,808 (65.8) 720 (68.8) 652 (73.1) 768 (72.9)
Grade III 284 (16.3) 276 (14.4) 505 (18.3) 169 (16.1) 122 (13.7) 149 (14.2)
Unknown 183 (10.5) 185 (9.7) 252 (9.2) 96 (9.2) 74 (8.3) 80 (7.6)
Stage
Stage I 317 (18.2) 386 (20.1) 476 (17.3) \0.001 310 (29.6) 333 (37.3) 380 (36.1) \0.001
Stage II 782 (44.9) 902 (47.1) 1,459 (53.1) 318 (30.4) 285 (32.0) 363 (34.5)
Stage III 641 (36.9) 628 (32.8) 814 (29.6) 419 (40.0) 274 (30.7) 310 (29.4)
Treatment
Only surgery 1,219 (70.1) 1,610 (84.0) 2,661 (96.8) \0.001 447 (42.7) 471 (52.8) 750 (71.2) \0.001
Surgery ? RT 12 (0.7) 18 (0.9) 4 (0.2) 449 (42.9) 370 (41.5) 295 (28.0)
Surgery ? CT 504 (28.9) 287 (15.0) 84 (3.0) 68 (6.5) 34 (3.8) 7 (0.7)
Surgery ? CT ? RT 5 (0.3) 1 (0.1) 0 (0.0) 83 (7.9) 17 (1.9) 1 (0.1)
Overall 1,740 (27.2) 1,916 (29.9) 2,749 (42.9) 1,047 (35.0) 892 (29.8) 1,053 (35.2)
RT radiotherapy, CT chemotherapy
First Year Accounts for Survival Differences 1535Apparently, the impact and consequences of treatment have
a prolonged effect on mortality. This effect is very strong
even for patients in the youngest group. With increasing
age, also the excess mortality increases. It has been shown
earlier that, with increasing age, not only mortality but also
postoperative morbidity increases.
12–14 Furthermore,
Manku et al. showed that in-hospital complications had
prognostic signiﬁcance.
15 In 517 patients who underwent
noncardiac surgery, they found that postoperative compli-
cations caused mortality up to 3 months after surgery, with
a sustaining effect on survival. Greenblatt et al. studied
stage I–III colon cancer patients from the Surveillance,
Epidemiology, and End Results–Medicare database and
found that readmission was strongly associated with 1-year
mortality.
16 The same variables that predicted readmission
in this study also predicted 1-year mortality (male gender,
comorbidity, emergent admission, prolonged hospital stay,
blood transfusion, ostomy, and discharge to a nursing
home). Kunitake et al. showed that patients older than
80 years were readmitted almost twice as much as patients
younger than 65 years.
17 Furthermore, in their study, 75%
of readmissions were not related to the surgery itself. With
the present study, all these studies seem to imply that, for a
signiﬁcant number of patients, the assault of surgery has
a
b
c
FIG. 1 a Overall survival according to age for stage I–III patients
operated for colon and rectal cancer. b Relative survival according to
age for stage I–III patients operated for colon and rectal cancer.
c Conditional relative survival (conditioning on patients who survived
1 year) according to age for stage I–III patients operated for colon and
rectal cancer
1536 J. W. T. Dekker et al.delayed effects that can cause mortality beyond the scope
of the surgery.
Stage III Patients
Only in stage III patients were age-related differences
found in conditional relative survival. Here, differences in
(neo)adjuvant therapy between the age groups were most
apparent. This is in line with earlier studies that show that
elderly patients are undertreated.
4 This undertreatment of
elderly patients could explain the age-related differences in
conditional relative survival for stage III patients. How-
ever, also in stage III patients, ﬁrst-year mortality remains a
crucial factor for survival. The difference in conditional
relative survival between young and elderly stage III
patients was 10.4% for colon and 5.6% for rectal cancer,
TABLE 2 Relative and conditional survival of operated stage I–III patients
Colon cancer All stages Stage I Stage II Stage III
RS CS RS CS RS CS RS CS
\65 years Ref Ref Ref Ref Ref Ref Ref Ref
65–74 years 1.2(1.0–1.4) 1.2 (1.0–1.4) 1.2 (0.6–2.4) 1.2 (0.6–2.5) 1.2 (0.9–1.5) 1.3 (1.0–1.8) 1.4 (1.2–1.7) 1.3 (1.0–1.6)
P-Value 0.01 0.03 0.7 0.5 0.2 0.04 \0.001 0.02
75 ? years 1.6 (1.4–1.9) 1.1 (0.9–1.4) 1.2 (0.5–2.8) N.A. 1.8 (1.4–2.2) 1.3 (0.9–1.8) 2.0 (1.6–2.3) 1.4 (1.1–1.8)
P-Value \0.001 0.2 0.7 0.99 \0.001 0.1 \0.001 0.003
Rectal cancer All stages Stage I Stage II Stage III
RS CS RS CS RS CS RS CS
\65 years Ref Ref Ref Ref Ref Ref Ref Ref
65–74 years 1.0 (0.8–1.2) 0.9 (0.7–1.1) 0.8 (0.4–1.8) 0.6 (0.3–1.5) 1.2 (0.8–1.6) 1.1 (0.8–1.7) 1.2 (0.9–1.5) 1.1 (0.8–1.4)
P-Value 0.8 0.2 0.6 0.3 0.4 0.6 0.1 0.6
75 ? years 1.4 (1.2–1.7) 1.1 (0.9–1.4) 1.7 (0.8–3.6) 0.3 (0.1–7.0) 1.6 (1.1–2.2) 1.4 (0.9–2.2) 1.8 (1.4–2.3) 1.5 (1.2–2.0)
P-Value \0.001 0.3 0.2 0.5 0.009 0.1 \0.001 0.002
RS relative survival, CS conditional survival, N.A. not addressed due to small numbers
TABLE 3 Overall 30-day and 1-year mortality and relative 1-year mortality rates in percentages according to type of tumor
Colon cancer Rectal cancer
Overall mortality Excess mortality Overall mortality Excess mortality
N B30 days 1st year 1st year N B30 days 1st year 1st year
Sex
Male 2,976 4.6 15.7 11.3 1,639 2.1 13.2 9.4
Female 3,429 4.1 14.5 10.9 1,353 1.3 9.9 6.9
Age (years)
\65 1,740 1.4 6.8 6.1 1,047 0.2 5.1 4.4
65–74 1,916 2.4 10.8 8.5 892 1.4 9.5 7.2
C75 2,749 7.5 23.2 16.0 1,053 3.7 20.1 13.1
Grade
I 436 2.1 9.9 6.0 162 3.1 8.0 4.9
II 4,284 4.4 12.6 8.5 2,140 1.8 10.2 6.6
III 1,065 4.7 25.2 21.3 440 1.6 22.3 19.5
Unknown 620 4.8 18.2 14.8 250 1.2 8.4 5.2
Stage
I 1,179 1.7 8.0 4.0 1,023 1.5 7.6 3.8
II 3,143 5.0 13.5 4.0 966 2.4 12.7 9.1
III 2,083 4.8 21.4 4.0 1,003 1.5 14.9 12.1
First Year Accounts for Survival Differences 1537while the differences in 1-year excess mortality rates were
17.2% and 12.0%, respectively.
Limitations
An obvious limitation of this study is the lack of infor-
mation on emergency surgery and comorbidity. Both are
associated with increased postoperative complications and
mortality. They will not only have had a prominent inﬂu-
ence on early mortality for all age groups, but they probably
account for the differences between the age groups as well.
Elderly patients are more likely to undergo emergency
surgery, and also the incidence of comorbidity increases
with age.
10 Nevertheless, the strength of this study is that it
shows the essence of age-related survival and early mor-
tality differences in a large population-based cohort.
Clinical Implications
The results of this study could provide a focus for future
studies and have implications for the clinical setting. As
age-related differences in mortality are most apparent for
the ﬁrst postoperative year, this is where the focus must be
in treating elderly colorectal cancer patients. Although
some risk factors may not be modiﬁable, others relate to
care processes. More attention should be given to patient
selection and careful preoperative evaluation, followed by
medical optimization, proper timing of surgery, and plan-
ning of perioperative care. Furthermore, appropriate
referral to high-volume or dedicated centers should be
considered if it is anticipated that patients will require a
higher level of resources and care following surgery.
Quality enhancement programs could focus on particular
complications. These should not only try to prevent the
occurrence of perioperative complications but also focus
on early identiﬁcation and adequate treatment of compli-
cations to avoid related mortality.
18
The excess mortality of the ﬁrst postoperative year
forms a clear indication of the prolonged impact of the
perioperative period, especially when complications occur.
Therefore, we should anticipate preoperatively the level of
functioning after discharge.
13 The targets of treatment for
elderly patients should extend beyond the in-hospital per-
iod, and continued attention should be given to comorbidity
and complications in the post-hospital period.
The prolonged impact of the perioperative period could
also have a profound effect on functional status and quality
of life. For elderly patients these issues should be evaluated
with care, especially when they have limited life expec-
tancies. However, for the majority of patients, age per se is
not a contraindication for surgery, not least because surgery
for colorectal cancer is often the best way to ensure
palliation.
CONCLUSIONS
This study can help to comprehend the challenge of
treating elderly colorectal cancer patients. When survival
data for colorectal cancer are corrected for expected death
from other causes and ﬁrst-year mortality, age differences
disappear. Therefore, decreased survival in the elderly is
mainly due to differences in early mortality. Only for stage
III disease did elderly patients fare worse, probably as a
result of less extensive adjuvant treatment. The overall
difference between the younger and elderly age groups is
that, within the elderly group, there is an excess mortality
of about 10% the ﬁrst year. Further studies are necessary to
elucidate the etiology of these differences and whether they
may be modiﬁable. This study implies that, in treating
elderly stage I–III colorectal cancer patients, the focus
should be on the perioperative process and the ﬁrst post-
operative year.
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